Crossing the Synapse: From Discovery to Innovation

Navigating Between Academia and Industry

Venue
Hotel Dubrovnik, Zagreb
Date
May 14-16, 2026

Welcome

Imagine a world where the next breakthrough in treating Alzheimer’s, stroke, malignant tumors, depression or any other major disease doesn’t remain trapped in a lab – but rapidly reaches patients and improves lives.

That world is closer than ever…but only if we finally close the translational gap!

Crossing the Synapse is the landmark symposium where the brightest minds in science, industry pioneers, clinicians, investors, and technology transfer experts come together to make it happen.

For two intensive days we will:

Expose the hidden roadblocks that slow promising discoveries
Showcase real-world success stories of therapies, devices and digital tools that made it from bench to bedside
Deliver concrete, actionable strategies and partnerships that accelerate translation
Forge new collaborations that turn today’s research into tomorrow’s treatments

This is not another academic conference. This is the moment where science meets scale, ideas meet impact, and discoveries finally cross the synapse into patients’ lives.

Join us!

Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union and European Commission. Neither the European Union nor the European Commission can be held responsible for them.

Zamislite svijet u kojem sljedeće ključno otkriće u liječenju Alzheimerove bolesti, moždanog udara, malignih tumora, depresije ili bilo koje druge velike bolesti ne ostaje zarobljeno u laboratoriju – već dospijeva do pacijenata u rekordnom vremenu.

Taj je svijet bliže nego ikada… ali samo ako zajednički napravimo nužan translacijski skok!

Crossing the Synapse: From Discovery to Innovation je simpozij koji okuplja stručnjake u području znanosti, industrije, kliničare, investitore i stručnjake za transfer tehnologije.

Ciljevi simpozija su:

Razotkriti skrivene prepreke koje usporavaju potrebna otkrića
Prikazati stvarne priče o uspjehu terapija i digitalnih alata koji su uspješno prešli put od laboratorija do pacijenta
Predstaviti konkretne, provedive strategije i partnerstva koja ubrzavaju prevođenje znanja u praksu
Uspostaviti nove suradnje koje će današnje istraživanje pretvoriti u sutrašnje tretmane

Ovo nije još jedna akademska konferencija. Ovo je trenutak u kojem se znanost susreće s potrebama, ideje se pretaču s konkretne rezultate, a otkrića konačno prelaze sinapsu, te pomažu pacijentima.

Pridružite nam se!

Izneseni stavovi i mišljenja samo su autorova i ne odražavaju nužno službena stajališta Europske unije ili Europske komisije. Ni Europska unija ni Europska komisija ne mogu se smatrati odgovornima za njih.

Info

Speakers

Sumaya Ali, Founder, DNM1 Epilepsy Foundation, US & Canada
Pavle Anđus, Chief Science Officer, dAIgnostics, Croatia
Ali Ardakani, Founder and Managing Director, Novateur Ventures, Canada
Fran Borovečki, General Director, Clinical Hospital Center Zagreb and EATRIS National Director, Croatia
Stephen R. Grobmyer, Institute Chief of Cleveland Clinic, UAE
Jasmina Isaković, Entrepreneur, EMHANCE d.o.o. and School of Medicine, EUC Frankfurt Branch, Germany
Mislav Jelić, Orthopedic Surgeon and Entrepreneur, Croatia
Gordan Lauc, Professor and Chief Executive Officer, Genos, Croatia
Nektarios Liaskos, Data Strategy Manager, EATRIS, Netherlands
Marija Lovrić, Chief Executive Officer, BICRO BIOCentre, Croatia
Gabriela Droga Mazovec, Head of the Department for the ID and Protection of IP, University of Ljubljana, Slovenia
Dinko Mitrečić, Professor and Expert Advisor, School of Medicine, University of Zagreb, Croatia
Riccardo Pietrabissa, Honorary President of Netval, Italy
Roland Pochet, Professor, European Brain Data Hub and ULB, Belgium
Carina Ruwolt, Director of Strategy, Pharmaceuticals division, Bayer, Germany
Prateek Singh, Investor, Cereal Fund; Chief Executive Officer & co-founder Proteins.1, Finland
Matija Srbić, Venture Builder, Nuqleus, Croatia
Zvonimir Vrselja, Chief Executive Officer, Bexorg, US
Milica Vukmirović, Founder and Chief Executive Officer, Move Venture Consulting, Canada

Sumaya Ali, osnivač, Zaklada DNM1 Epilepsy, SAD i Kanada
Pavle Anđus, direktor znanstvenih istraživanja, dAIgnostics, Hrvatska
Ali Ardakani, osnivač i direktor, Novateur Ventures, Kanada
Fran Borovečki, ravnatelj i nacionalni direktor, KBC Zagreb i EATRIS, Hrvatska
Stephen R. Grobmyer, Direktor instituta Klinike Cleveland, UAE
Jasmina Isaković, poduzetnica, EMHANCE d.o.o. i Medicinski fakultet, EUC Frankfurt, Njemačka
Mislav Jelić, specijalist ortoped i poduzetnik, Hrvatska
Gordan Lauc, profesor i generalni direktor, Genos, Hrvatska
Nektarios Liaskos, voditelj upravljanja podacima, EATRIS, Nizozemska
Marija Lovrić, generalna direktorica, BICRO Biocentar, Hrvatska
Gabriela Droga Mazovec, voditelj Odsjeka za zaštitu intelektualnog vlasništva, Sveučilište u Ljubljani, Slovenija
Dinko Mitrečić, profesor i konzultant, Sveučilište u Zagrebu, Medicinski fakultet, Hrvatska
Riccardo Pietrabissa, Počasni predsjednik Netvala, Italija
Roland Pochet, profesor, European Brain Data Hub i ULB, Belgija
Carina Ruwolt, direktorica, Sektor za strateški razvoj farmaceutike, Bayer, Njemačka
Prateek Singh, investitor, Zaklada Cereal, generalni direktor i osnivač, Proteins.1, Finska
Matija Srbić, savjetnik u poduzetništvu, Nuqleus, Hrvatska
Zvonimir Vrselja, poduzetnik i znanstvenik, Bexorg, SAD
Milica Vukmirović, osnivač i direktor, Move Venture Consulting, Kanada

Program

Accommodation

Registration

Company

This field is for validation purposes and should be left unchanged.

Name(*)

First Last

Institution/Firm(*)

ADDRESS(*)

Street Address City broj Country

PHONE(*)

E-MAIL(*)

Datum

REGISTRATION FEE(*)

GRATIS